静脉注射免疫球蛋白可减少实验性大疱性类天疱疮模型中的致病性自身抗体、血清IL-6水平及疾病严重程度
研究利用两种实验性大疱性类天疱疮(BP)小鼠模型,探讨静脉注射免疫球蛋白(IVIG)的作用及机制。IVIG在被动转移和主动免疫模型中均降低致病性IgG和疾病评分,并抑制IL-6升高,可能通过抑制角质形成细胞产生IL-6。结果提示IVIG对BP的抑制作用与减少致病性IgG和调节细胞因子产生相关。
要点
- IVIG在两种实验性BP小鼠模型中均降低致病性IgG和疾病评分。
- IVIG抑制两种模型中IL-6的升高,可能通过抑制角质形成细胞产生IL-6。
- IVIG注射后分布于真皮及下表皮细胞间隙。
核心结论
- IVIG对BP的抑制作用与减少致病性IgG和调节细胞因子产生相关。
研究设计与样本
- 采用两种实验性BP小鼠模型进行IVIG实验:被动转移模型(新生小鼠经被动转移抗COL17的IgG复制表皮下分离)和主动BP模型(成年小鼠持续出现疾病表型)。
主要发现
- IVIG在被动转移和主动BP模型中均降低致病性IgG和疾病评分。
- 注射的IVIG分布于真皮和下表皮细胞间隙。
- IVIG在两种模型中抑制IL-6升高,可能通过抑制角质形成细胞产生IL-6。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by autoantibodies to COL17. Currently, systemic corticosteroids are used as first-line treatments for BP; alternatively, intravenous administration of high-dose IgG (IVIG) has been shown to be effective for patients with steroid-resistant BP in clinical practice. However, the effect of IVIG on BP has not fully been investigated. To examine the effects and mechanisms of action of IVIG against BP, we performed IVIG experiments using two experimental BP mouse models. One is a passive-transfer BP model that reproduces subepidermal separation in neonatal mice by the passive transfer of IgGs against COL17, such as polyclonal or monoclonal mouse IgG or IgG from BP patients. The other is an active BP model that continuously develops a disease phenotype in adult mice. IVIG decreased pathogenic IgG and the disease scores in both models. Injected IVIG distributed throughout the dermis and the intercellular space of the lower epidermis. Notably, IVIG inhibited the increase of IL-6 in both models, possibly by suppressing the production of IL-6 by keratinocytes. These results suggest that the inhibitory effects of IVIG on BP are associated with the reduction of pathogenic IgG and the modulation of cytokine production.
引用
- Sasaoka T, Ujiie H, Nishie W, et al. Intravenous IgG Reduces Pathogenic Autoantibodies, Serum IL-6 Levels, and Disease Severity in Experimental Bullous Pemphigoid Models. J Invest Dermatol. 2018. PMID: 29391250. doi:10.1016/j.jid.2018.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。